There are possibilities and limitations to any cancer treatment, where the expectation of a favorable outcome might only hold true for a subset of patients. This is the case for most immunotherapies....
Sometimes research has lucky stories behind it that should be told. We usually think of a Master's thesis as another task to earn the degree certificate, but once in a blue moon...
The yearly burden of cancer is expected to increase in the 28 EU member states from 3.0 mio cases in 2018 to around 4.0 mio new cases in 2040. Over this period,...
At the EACR Virtual Congress in June Dr. Nitzan Rosenfeld gave his keynote lecture as the winner of the 2020 Pezcoller Foundation – EACR Cancer Researcher Award. What is the award? The...
The COVID-19 crisis meant a lot of people had to change their plans for 2020 very quickly. We weren't able to hold our Congress in Torino this year, but we were able...
At the Virtual EACR Congress in June, we gathered senior editors from top cancer research journals for an insightful discussion about scientific publication. Professors Alberto Bardelli & Caroline Dive chaired a discussion...
The COVID-19 pandemic has changed the way the cancer research community operates and the EACR has also adapted during these times. In April we decided to postpone or cancel all of our...
Over three months ago, I left the lab and my home became my new work environment. In our shared house, our rooms became offices and my "colleagues" in the building have different...
Martina Gasull (Biomedical Genomics Lab, IRB Barcelona) writes a scientific communication blog in Catalan and Spanish, and in the early days of the COVID-19 lockdown she interviewed her colleague Francisco Martínez-Jiménez, a...
© 2025 EACR
